Press Room

2021 CPhI Japan

Start
Wednesday, April 14, 2021 - 00:00
End
Friday, April 30, 2021 - 00:00
Location: Osaka, Japan
Drug Product Dry Granulation | Hovione

If you are attending CPhI Japan and would like to chat with us about your challenges, schedule a meeting with us. Yasushi Usuda will be pleased to meet you.

With more than 25 years’ experience in Inhalation, Hovione is your solution partner from early proof-of-concept to commercial scale manufacture.

yasushi-usuda-photo

Yasushi Usuda

Director of Japan Office

 

 

CPhI Japanに出展するホビオンをご覧ください。また、今から面談をご予約しませんか。

​​​​​Visit Hovione at CPhI Japan Connect and schedule a meeting.

 

 

Webinar (available in English)

Title: “Leveraging Particle Engineering towards the Delivery of Biopharmaceuticals”

Date/ Time: April 15th, 2:00 pm JST

 

Watch On-Demand Webinar

(Restricted content)

 
Biopharmaceuticals represent the most promising and fastest-growing field in the pharmaceutical area. These therapeutics show very high specificity and potency at relatively low concentrations and enable the treatment of otherwise untreatable diseases.

 

 

What can you learn from this webinar?

  • Formulation screening for biologics
  • Spray drying of monoclonal antibodies
  • Spray freeze drying
  • Pulmonary Delivery of enzymes
  • A series of case-studies will also be shown for each of the relevant technologies.
     

Speakers:

Paulo Lino, PhD - Scientist, R&D Drug Product Development
João Sá, PhD - Scientist, R&D Drug Product Development

 

 

Watch On-Demand Webinar

(Restricted content)

 

Our experts are available to address all challenges, helping your projects to succeed.

 

Schedule a meeting button | Hovione

 

 

 

 

Also in the Press Room

See All

The global inhalation contract development and manufacturing organization (CDMO) market is projected to grow from USD 9.13 billion in 2025 to USD 16.68 billion by 2035, reflecting a compound annual growth rate (CAGR) of 5.7% during the forecast period. This growth is driven by the increasing prevalence of respiratory diseases, advancements in inhalation drug delivery technologies, and the rising demand for outsourced manufacturing services in the pharmaceutical industry. The inhalation CDMO market has emerged as a pivotal segment in the pharmaceutical contract development and manufacturing industry. With a rising demand for inhaled therapies for conditions like asthma, COPD, and cystic fibrosis, companies are increasingly outsourcing drug development and production to specialized partners. Inhalation CDMO services cater to both large pharmaceutical corporations and small biotech firms, offering expertise in formulation, device compatibility, regulatory support, and scale-up manufacturing. This market is gaining traction due to the complexity of inhalation drug delivery, which often requires niche technical capabilities and specialized equipment. Outsourcing to an inhalation CDMO allows drug developers to reduce time-to-market while ensuring quality and compliance with global standards. (...) Top Companies Several players dominate the inhalation CDMO market through technological expertise, global reach, and service portfolio diversity: (...) Hovione – Offers particle engineering and inhalation development, with a focus on dry powder inhalers. (...) These companies are continually investing in facilities, talent, and technology to meet evolving customer needs in the inhalation CDMO market.   Read the full article on Pharmiweb.com        

Press Clipping

Inhalation CDMO Market Growth Analysis & Forecast 2025 to 2035

Jun 25, 2025